Old Web
English
Sign In
Acemap
>
Paper
>
Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study
Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study
2020
Juergen Wolf
Takashi Seto
J. Y. Han
Noemi Reguart
EB Garon
H. Groen
D.S.W. Tan
Toyoaki Hida
M.J.A. de Jonge
Sergey Orlov
Egbert F. Smit
P.J. Souquet
Johan Vansteenkiste
S Le Mouhaer
Anna Robeva
Maeve Waldron-Lynch
Alejandro Balbin
L. Fairchild
Monica Giovannini
Rebecca S. Heist
Keywords:
Capmatinib
Cancer research
Medicine
Oncology
in patient
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]